1126 NEW ZEALAND GAZETTE No. 55

Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any)

--- | --- | --- | ---
Doxorubicin hydrochloride 2 mg/ml | Solution for injection (vials) | David Bull Laboratories Pty Limited, Mulgrave North, Victoria, Australia | Doxorubicin hydrochloride injection
Doxorubicin hydrochloride 10 mg, 50 mg | Powder for reconstitution for injection | David Bull Laboratories Pty Limited, Mulgrave North, Victoria, Australia | Doxorubicin for injection
Doxorubicin hydrochloride 2 mg/ml | Injection (syringe) | David Bull Laboratories Pty Limited, Mulgrave North, Victoria, Australia | Doxorubicin hydrochloride syringe
Vincristine sulphate 1 mg/ml | Solution for injection | Lyphomed Inc., Melrose Park, Illinois, United States of America | Vincristine sulphate injection
Heparin sodium 50 iu in 5 ml | Solution for injection | Delta West Pty Limited, Bentley, Western Australia | Heparinised saline
Doxorubicin hydrochloride 10 mg, 50 mg | Powder for reconstitution for injection | Pharmachemie BV, Haarlem, The Netherlands | Doxorubin
Passiflora incarnata 22 mg | Tablets | English Grains (Holdings) Limited, Overseal, Burton on Trent, Staffordshire, England | Naturest
Clarithromycin 250 mg | Tablet | Abbott Australasia Pty Limited, Kurnell, New South Wales, Australia, or Abbott Laboratories Limited, Queensborough, Kent, England, or Abbott SpA, Campoverde de Aprilia, (Latina), Italy | Klacid
Prazosin hydrochloride 1 mg, 2 mg, 5 mg | Tablets | Glaxo New Zealand Limited, Palmerston North | Prazosin
Diclofenac sodium 25 mg, 50 mg | Tablet | Apotex Inc., Weston, Ontario, Canada | Diclofenac EC

Dated this 9th day of April 1992.

C. LOVEACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.
go3553

Consent to the Distribution of a Changed Medicine

Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine set out in the Schedule hereto:

Schedule

Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any)

--- | --- | --- | ---
Interferon alpha-2B 1 million iu, 3 million iu, 5 million iu, 9 million iu, 10 million iu, 30 million iu | Powder for reconstitution for injection | Schering Plough (Brinnny) Co., Innishannon, Co. Cork, Ireland | Intron-A

Dated this 9th day of April 1992.

C. LOVEACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.
go3554

Justice

District Courts Act 1947

Extension of District Court Judge’s Jurisdiction

Pursuant to section 28B of the District Courts Act 1947, Her Excellency the Governor-General has been pleased to appoint

Anne Elvera Gaskell

to exercise the criminal jurisdiction of the District Courts under Part IIA of the District Courts Act 1947.

Dated at Wellington this 30th day of March 1992.

D. A. M. GRAHAM, Minister of Justice.
go3558

Oaths and Declarations Act 1957

Officers in the Selwyn District Council Authorised to Take Statutory Declarations

Pursuant to section 9 of the Oaths and Declarations Act 1957, I hereby authorise the holders for the time being of the offices

in the service of the local authority specified in the Schedule below to take statutory declarations under the said Act.

Schedule

Selwyn District Council

• General Manager.
• Manager, Professional Engineering Business Centre
• Executive Officer.

Dated at Wellington this 2nd day of April 1992.

D. A. M. GRAHAM, Minister of Justice.
(Adm. 3/28/3/3)
go3568

Resource Management Act 1991

Planning Tribunal Appointment

Pursuant to section 254 of the Resource Management Act 1991, Her Excellency the Governor-General has been pleased to reappoint